Skip to main content
. 2022 Jun 8;13:921963. doi: 10.3389/fphar.2022.921963

FIGURE 2.

FIGURE 2

(Continued). Prognostic values of FANCD2, SLC40A1, EGFR, TF, and GABARAPL1 in GBM patients (A–E) CGGA database indicated the prognostic values of FANCD2, SLC40A1, EGFR, TF, and GABARAPL1 in patients with primary and recurrent glioma.